These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 312241

  • 1. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH, Bryce GF.
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [Abstract] [Full Text] [Related]

  • 2. The acute pharmacologic effects of serotonin on the release of insulin and glucagon in the intact rat.
    Jacoby JH, Bryce GF.
    Arch Int Pharmacodyn Ther; 1978 Oct; 235(2):254-70. PubMed ID: 310665
    [Abstract] [Full Text] [Related]

  • 3. Serotonergic stimulation of prolactin release in the young turkey (Meleagris gallopavo).
    Fehrer SC, Silsby JL, El Halawani ME.
    Gen Comp Endocrinol; 1983 Dec; 52(3):400-8. PubMed ID: 6230284
    [Abstract] [Full Text] [Related]

  • 4. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
    Fuller RW, Snoddy HD, Clemens JA.
    Endocr Res Commun; 1978 Dec; 5(2):161-71. PubMed ID: 309816
    [Abstract] [Full Text] [Related]

  • 5. Antagonism by ketanserin of the behavioral effects of quipazine but not l-5-hydroxytryptophan in squirrel monkeys.
    Witkin JM, Brady LS, Barrett JE.
    Psychopharmacology (Berl); 1988 Dec; 94(3):302-5. PubMed ID: 3128804
    [Abstract] [Full Text] [Related]

  • 6. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM, Gala RR.
    Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
    [No Abstract] [Full Text] [Related]

  • 7. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA, Kuhn CM.
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [Abstract] [Full Text] [Related]

  • 8. Fluoxetine impairs insulin secretion without modifying extracellular serotonin levels in MIN6 β-cells.
    Cataldo LR, Cortés VA, Mizgier ML, Aranda E, Mezzano D, Olmos P, Galgani JE, Suazo J, Santos JL.
    Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):473-8. PubMed ID: 26011169
    [Abstract] [Full Text] [Related]

  • 9. The effects of quipazine and fluoxetine on extinction of a previously-reinforced operant response in rats.
    Beninger RJ.
    Pharmacol Biochem Behav; 1984 Oct; 21(4):533-7. PubMed ID: 6334317
    [Abstract] [Full Text] [Related]

  • 10. Effect of quipazine and fluoxetine on analgesic-induced catalepsy and antinociception in the rat.
    Malec D, Langwinski R.
    J Pharm Pharmacol; 1980 Jan; 32(1):71-3. PubMed ID: 6102137
    [No Abstract] [Full Text] [Related]

  • 11. Effects of the chronic ingestion of therapeutic doses of chlorimipramine on the behavioral action of agonists and antagonists of serotonin in male rats.
    Rodríguez Echandía EL, Broitman ST, Fóscolo MR.
    Pharmacol Biochem Behav; 1983 Aug; 19(2):193-7. PubMed ID: 6605538
    [Abstract] [Full Text] [Related]

  • 12. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L, McCann SM, Mayfield MA.
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [Abstract] [Full Text] [Related]

  • 13. Quipazine-induced head-twitch in mice.
    Malick JB, Doren E, Barnett A.
    Pharmacol Biochem Behav; 1977 Mar; 6(3):325-9. PubMed ID: 140381
    [Abstract] [Full Text] [Related]

  • 14. Effects of quipazine on blood pressure in pithed rats.
    Shin YK, Svinareff P, Schmitt-Jubeau H, Schmitt H.
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [Abstract] [Full Text] [Related]

  • 15. The serotonin autoreceptor: antagonism by quipazine.
    Martin LL, Sanders-Bush E.
    Neuropharmacology; 1982 May; 21(5):445-50. PubMed ID: 6981071
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of imipramine-induced rat brain beta-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan.
    Alhaider AA, Mustafa AA.
    Psychopharmacology (Berl); 1991 May; 103(3):351-6. PubMed ID: 1647538
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.